Get the Stockscreener App
2.00
1.01%
0.02
After Hours:
2.04
0.04
+2.00%
Tenaya Therapeutics Inc stock is traded at $2.00, with a volume of 6.09M.
It is up +1.01% in the last 24 hours and up +66.67% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.98
Open:
$1.98
24h Volume:
6.09M
Relative Volume:
1.66
Market Cap:
$325.95M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-1.5152
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+12.99%
1M Performance:
+66.67%
6M Performance:
+308.16%
1Y Performance:
+18.34%
1-Day Range:
$1.88
$2.07
1-Week Range:
$1.7201
$2.35
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
2.00 | 322.69M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Does Tenaya Therapeutics Inc. show high probability of reboundWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Statistical indicators supporting Tenaya Therapeutics Inc.’s strengthJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Applying chart zones and confluence areas to Tenaya Therapeutics Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Will Tenaya Therapeutics Inc. stock continue dividend increasesJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Intraday pattern recognizer results for Tenaya Therapeutics Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
Momentum divergence signals in Tenaya Therapeutics Inc. chartJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - newser.com
What Fibonacci levels say about Tenaya Therapeutics Inc. reboundJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
What to expect from Tenaya Therapeutics Inc. in the next 30 daysJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.July 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
What analysts say about Tenaya Therapeutics Inc stockEarnings Call Summaries & Affordable Growth Trading - earlytimes.in
Tenaya Therapeutics (TNYA): Evaluating Valuation After Investor Buzz on MyPEAK-1 and RIDGE-1 Clinical Updates - Yahoo Finance
Real time scanner hits for Tenaya Therapeutics Inc. explainedEarnings Trend Report & Verified Entry Point Signals - newser.com
Tenaya Therapeutics Stock (TNYA) Opinions on CEO Conference Appearances - Quiver Quantitative
When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - 富途牛牛
Why Tenaya Therapeutics Inc. stock appeals to analystsDay Trade & AI Powered Market Trend Analysis - newser.com
Tenaya Therapeutics (NASDAQ:TNYA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - The Manila Times
Fireside chat Oct 14: Tenaya Therapeutics CEO Faraz Ali at H.C. Wainwright; 1x1 meetings Oct 15, replay 30 days - Stock Titan
Can Tenaya Therapeutics’ Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? - Yahoo Finance
Using RSI to spot recovery in Tenaya Therapeutics Inc.Earnings Beat & Accurate Technical Buy Alerts - newser.com
How Might Tenaya Therapeutics' (TNYA) Industry Visibility Influence Its Strategic Positioning? - Sahm
Is now a turning point for Tenaya Therapeutics Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Does Tenaya Therapeutics Inc. fit your quant trading model2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
What recovery options are there for Tenaya Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Tenaya Therapeutics CEO Faraz Ali to Speak at Upcoming Investor and Industry Conferences in October 2025 - Quiver Quantitative
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - The Manila Times
Oct 6 & Oct 21: Tenaya Therapeutics CEO Faraz Ali to Present at Investor Conferences — Webcast Archived 30 Days - Stock Titan
Will Strategic Partnerships Propel SP Refractories Limited Higher in YEARExit Strategy Tips & Maximize Returns With Insights - earlytimes.in
How to manage a losing position in Tenaya Therapeutics Inc.Market Trend Report & Weekly Stock Breakout Alerts - newser.com
What sentiment indicators say about Tenaya Therapeutics Inc. stockEarnings Overview Summary & Step-by-Step Swing Trade Plans - newser.com
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tenaya Therapeutics Inc Stock (TNYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):